Inhoud
COPD en astma.......................................................................................................................................4
Spirometrische waarden.....................................................................................................................4
Processen betrokken bij de gaswisseling............................................................................................4
Mechanismen van luchtwegobstructie...............................................................................................4
Astma en COPD: overeenkomsten......................................................................................................5
Hyperreactiviteit.................................................................................................................................5
Astma bronchiale: pathofysiologie en symptomen............................................................................5
COPD: definitie en kenmerken...........................................................................................................7
Emfyseem: pathogenese, pathofysiologie, symptomen.....................................................................7
Begrippen...........................................................................................................................................8
Samenvatting......................................................................................................................................8
Algemene oncologie...............................................................................................................................9
Cel- en weefselveranderingen............................................................................................................9
Kenmerken van benigne versus maligne tumoren.............................................................................9
Naamgeving van tumoren................................................................................................................11
Oorzakelijke factoren van kanker.....................................................................................................11
Premaligne afwijkingen....................................................................................................................11
Metastasering (uitzaaiing)................................................................................................................11
Symptomatologie.............................................................................................................................13
Diagnostiek en stadiëring.................................................................................................................13
Therapie...........................................................................................................................................13
Borstkanker......................................................................................................................................14
Begrippen.........................................................................................................................................14
Samenvatting....................................................................................................................................14
Diabetes mellitus..................................................................................................................................15
Inleiding: werkingsmechanisme van hormonen...............................................................................15
Effecten van insuline versus glucagon..............................................................................................15
Diabetes mellitus pathofysiologie.....................................................................................................15
Oorzaken van diabetes type 1 versus type 2....................................................................................15
Diagnostiek.......................................................................................................................................15
Symptomatologie.............................................................................................................................15
Complicaties op langere termijn.......................................................................................................17
Diabetes ontregelingen....................................................................................................................17
Complicaties op korte termijn..........................................................................................................17
, Hypoglycemische ontregeling...........................................................................................................17
Hyperglycemische ontregeling.........................................................................................................18
Begrippen.........................................................................................................................................18
Samenvatting....................................................................................................................................18
Reumatoïde artritis...............................................................................................................................19
Definitie en indeling van reumatische ziekten..................................................................................19
Anatomie van synoviaal gewricht.....................................................................................................19
Reumatoïde artritis...........................................................................................................................19
Inleiding en epidemiologie...............................................................................................................19
Pathogenese/pathofsyiologie...........................................................................................................19
Symptomatologie.............................................................................................................................19
Diagnostiek.......................................................................................................................................21
Therapie...........................................................................................................................................21
Begrippen.........................................................................................................................................21
Samenvatting....................................................................................................................................21
Dementie..............................................................................................................................................22
Neurocognitieve domeinen..............................................................................................................22
DSM 4...............................................................................................................................................22
Beloop..............................................................................................................................................22
Alzheimer dementie (70%)...............................................................................................................22
Lewybody dementie (10%)...............................................................................................................22
Vasculaire dementie (20%)...............................................................................................................22
Global deterioration scale (GDS)......................................................................................................22
Behandelen.......................................................................................................................................24
ROB...................................................................................................................................................24
Validation.........................................................................................................................................24
Warme zorg......................................................................................................................................24
PDL...................................................................................................................................................24
Van de Rakt-methode.......................................................................................................................24
Begrippen.........................................................................................................................................24
Samenvatting....................................................................................................................................24
Hart-en vaatziekten..............................................................................................................................25
Atherosclerose..................................................................................................................................25
Angina pectoris.................................................................................................................................25
Myocardinfarct.................................................................................................................................27
Hartfalen...........................................................................................................................................27
, Begrippen.........................................................................................................................................28
Samenvatting....................................................................................................................................28
COPD en astma.......................................................................................................................................4
Spirometrische waarden.....................................................................................................................4
Processen betrokken bij de gaswisseling............................................................................................4
Mechanismen van luchtwegobstructie...............................................................................................4
Astma en COPD: overeenkomsten......................................................................................................5
Hyperreactiviteit.................................................................................................................................5
Astma bronchiale: pathofysiologie en symptomen............................................................................5
COPD: definitie en kenmerken...........................................................................................................7
Emfyseem: pathogenese, pathofysiologie, symptomen.....................................................................7
Begrippen...........................................................................................................................................8
Samenvatting......................................................................................................................................8
Algemene oncologie...............................................................................................................................9
Cel- en weefselveranderingen............................................................................................................9
Kenmerken van benigne versus maligne tumoren.............................................................................9
Naamgeving van tumoren................................................................................................................11
Oorzakelijke factoren van kanker.....................................................................................................11
Premaligne afwijkingen....................................................................................................................11
Metastasering (uitzaaiing)................................................................................................................11
Symptomatologie.............................................................................................................................13
Diagnostiek en stadiëring.................................................................................................................13
Therapie...........................................................................................................................................13
Borstkanker......................................................................................................................................14
Begrippen.........................................................................................................................................14
Samenvatting....................................................................................................................................14
Diabetes mellitus..................................................................................................................................15
Inleiding: werkingsmechanisme van hormonen...............................................................................15
Effecten van insuline versus glucagon..............................................................................................15
Diabetes mellitus pathofysiologie.....................................................................................................15
Oorzaken van diabetes type 1 versus type 2....................................................................................15
Diagnostiek.......................................................................................................................................15
Symptomatologie.............................................................................................................................15
Complicaties op langere termijn.......................................................................................................17
Diabetes ontregelingen....................................................................................................................17
Complicaties op korte termijn..........................................................................................................17
, Hypoglycemische ontregeling...........................................................................................................17
Hyperglycemische ontregeling.........................................................................................................18
Begrippen.........................................................................................................................................18
Samenvatting....................................................................................................................................18
Reumatoïde artritis...............................................................................................................................19
Definitie en indeling van reumatische ziekten..................................................................................19
Anatomie van synoviaal gewricht.....................................................................................................19
Reumatoïde artritis...........................................................................................................................19
Inleiding en epidemiologie...............................................................................................................19
Pathogenese/pathofsyiologie...........................................................................................................19
Symptomatologie.............................................................................................................................19
Diagnostiek.......................................................................................................................................21
Therapie...........................................................................................................................................21
Begrippen.........................................................................................................................................21
Samenvatting....................................................................................................................................21
Dementie..............................................................................................................................................22
Neurocognitieve domeinen..............................................................................................................22
DSM 4...............................................................................................................................................22
Beloop..............................................................................................................................................22
Alzheimer dementie (70%)...............................................................................................................22
Lewybody dementie (10%)...............................................................................................................22
Vasculaire dementie (20%)...............................................................................................................22
Global deterioration scale (GDS)......................................................................................................22
Behandelen.......................................................................................................................................24
ROB...................................................................................................................................................24
Validation.........................................................................................................................................24
Warme zorg......................................................................................................................................24
PDL...................................................................................................................................................24
Van de Rakt-methode.......................................................................................................................24
Begrippen.........................................................................................................................................24
Samenvatting....................................................................................................................................24
Hart-en vaatziekten..............................................................................................................................25
Atherosclerose..................................................................................................................................25
Angina pectoris.................................................................................................................................25
Myocardinfarct.................................................................................................................................27
Hartfalen...........................................................................................................................................27
, Begrippen.........................................................................................................................................28
Samenvatting....................................................................................................................................28
